Healthcare

CSL Ltd Shows Steady Growth with Solid Financials

Highlights,CSL Ltd continues to show steady revenue growth with rising profits.,The company's debt/equity ratio indicates a strong capital structure.,...

ASX health stocks confirming FY25 projections noted

Highlights,Market Trends: The ASX health stocks experienced a decline of approximately 0.9% over the past five days, while the broader market fell by...

Arovella Strengthens Cash Position with $3 Million R&D Refund and Pr...

Highlights,Arovella,secures a $3 million R&D tax refund for FY2024, with more funding expected.,Progress,continues on,ALA-101 as the company prepares...

Live Verdure Ltd. Records the Issuance of 1 Million New Securities

Highlights,Live Verdure Ltd has announced the quotation of 1,000,000 new ordinary fully paid securities on the Australian Securities Exchange (ASX) un...

Telix and Banks Boost ASX Performance, While Newmont and Fortescue S...

Highlights,Australian shares closed modestly lower following a mixed trading session, with significant impacts from disappointing updates in the minin...

InhaleRx Limited's Share Count Increased by Nearly 18 Million

Highlights,InhaleRx Limited has listed nearly 18 million fully paid ordinary shares on the ASX.,This move follows a series of market transactions that...

ResMed's Share Price Surge and the Healthcare Sector’s Growth Potent...

Highlights,ResMed share price has climbed significantly since the start of 2024.,Healthcare stocks, like ResMed, tend to offer consistent revenue due...

EBOS Group Navigates Changing Pharmaceutical Landscape

Highlights,EBOS Group reports growth despite industry challenges.,Cann Group sees production gains, but financial pressures persist.,Atomo Diagnostics...

4DMedical Receives $1.9 Million Grant to Expand Trials for Advanced...

Highlights:,4DMedical Ltd (ASX:4DX) has secured $1.9 million from the Australian Federal Government to expand clinical trials for its,CT:VQ,lung imagi...

Aroa Biosurgery Sees Revenue Growth and Expands US Operations

Highlights,Aroa Biosurgery sees strong revenue growth and reduced cash outflow.,Key products like Myriad and,OviTex,continue to drive sales across mul...

Life Sciences Sector Reports Mixed Results as Quarterly Updates Roll...

Highlights,Quarterly reports show mixed results for life sciences companies.,Next Science shares drop significantly after sales decline.,Aroa Biosurge...

Insights into CSL Share Price Movement Being Gathered in 2024

Highlights,CSL’s Share Price Growth:,CSL Ltd (ASX: CSL) has seen a 3.1% increase in share price since the start of 2024, reflecting its stable market...

InhaleRx Shares Surge by 36% on Significant Funding Agreement Announ...

Highlights,The company has secured funding of up to $38.5 million from Clendon Biotech Capital.,Funding to support IRX-211 (for breakthrough cancer pa...

Telix Pharmaceuticals Announces Proposed Nasdaq Listing

Highlights,Telix to list ADSs on Nasdaq under ticker,"TLX",.,Part of Telix's plan to broaden its global investor base and enhance its U.S. operations....

Tryptamine Therapeutics Completes Phase 1b Trial for Psilocin Formul...

Highlights,Tryptamine Therapeutics completes safety evaluation of TRP-8803.,The trial showed positive safety results with IV-infused psilocin treatmen...

Telix (ASX:TLX) Targets Sales Growth with New Cancer Treatments and...

Highlights,Telix Pharmaceuticals plans to double sales with new cancer treatment products.,Illuccix sales expected to expand with upcoming regulatory...

Latin Resources Advances at Colina Lithium Project with Key Achievem...

Highlights:,Latin Resources Limited is focused on advancing its Colina Lithium Project in Brazil, having defined a maiden mineral resource of 45.2 mil...

InhaleRX Raises $38.5 Million from Clendon for Biotech Initiatives

Highlights:,InhaleRX initiates clinical trials for cannabis-based compounds aimed at pain management and mental health.,The company has secured signif...

Tryptamine Therapeutics Marks Safety Milestone in Psilocin IV Infusi...

Highlights,Tryptamine Therapeutics Ltd achieves safety milestone in psilocin IV infusion trial.,TRP-8803,deemed,safe after Phase 1b study involving 11...

Telix Pharmaceuticals' Quarterly Revenue Exceeds AU$200M Mark

Highlights,Telix,Pharmaceuticals reports AU$201M in quarterly revenue,.,Sales growth driven by,prostate,cancer imaging product,,Illuccix,.,Company exp...